WINDTREE THERAPEUTICS INC /DE/ Lessee, Operating Lease, Liability, Undiscounted Excess Amount
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $87.00 thousand as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2025-04-15
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $87.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $182.00K.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $309.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $473.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2024-12-31 | $87.00K 10-K · filed 2025-04-15 |
| 2023-12-31 | $182.00K 10-K · filed 2024-04-16 |
| 2022-12-31 | $309.00K 10-K · filed 2023-03-31 |
| 2021-12-31 | $473.00K 10-K · filed 2022-03-31 |
| 2020-12-31 | $57.00K 10-K · filed 2021-03-29 |
| 2019-12-31 | $149.00K 10-K · filed 2020-04-03 |
| 2019-09-30 | $184.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $210.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $260.00K 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |